Clinical trial
The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A…
NCT00318201 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00318201 |
|---|---|
| Title | The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers |
| Official title | The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers |
| Lead sponsor | Indiana University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Erythromycin, Diltiazem |
| Enrollment | 7 |
| Start date | Apr 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Apr 26, 2006 |
| Last update posted | Apr 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: